- Clinical Associate Professor, Global Health
India
Select from the following:
Sonali Kochhar MD has over 23 years of leadership experience for global vaccines and drugs development, Phase I-IV clinical research, safety, epidemiology and implementation research; Infectious diseases (e.g. COVID-19, HIV/AIDS, TB, malaria, influenza, GBS, RSV); maternal immunization; pandemics preparedness and response; new vaccines introduction; increasing immunization coverage and acceptance; and immunization programs strengthening. Her work has informed global vaccine policy recommendations.
Dr Kochhar has led multiple vaccines development and research programs in Kenya, Uganda, Zambia, The Gambia, South Africa, the United States, Belgium, Germany, India, Bangladesh and Nepal, and has co-authored internationally accepted guidance, protocol templates and AEFI case definitions.
She serves on advisory panels including the WHO SAGE; WHO SAGE Working Group (WG) on COVID-19 vaccines; WHO GACVS WG on COVID-19 Vaccines Safety Preparedness; Co-Chair of the WHO ACT-Accelerator Ethics & Governance WG; Wellcome Trust’s Independent Review Panel for Clinical Study Data Requests, as Guest Faculty for International Vaccinology Programs, and has published over 120 publications.
- MD (University of Delhi)
- MBBS (University of Delhi)
- English
- Hindi
- Bioethics
- Burden of Disease
- Business and Public Private Partnerships
- COVID-19
- Delivery Logistics
- Diarrheal Diseases
- Disease Surveillance
- Drug and Vaccine Development
- Ebola
- Epidemiology
- Global Health Governance
- Health Outcomes
- Health Policy and Advocacy
- Health Systems Strengthening and Human Resources Development
- HIV/AIDS
- Immunizations
- Implementation Science
- Infectious Diseases
- Influenza
- Leishmaniasis
- Malaria
- Maternal Child Health (incl. Reproductive Health)
- Metrics and Evaluation
- Neglected Diseases, Tropical Medicine (incl. Parasites)
- Viruses
- Building functional Pharmacovigilance (PV) systems in LMICs
- COVID-19 Outbreak Expert group member for the UK Government
- COVID-19 vaccines development, safety assessment and utilization
- IMPRINT (Immunizing Pregnant Women and Infants)
- WHO Evidence Considerations for Vaccine Policy (ECVP) framework
- WHO Global Advisory Committee on Vaccine Safety (GACVS) has endorsed the templates and they are being utilized by COVID-19 vaccine developers (including those funded by CEPI)
COVID-19 Vaccine Safety Questions and Answers for Healthcare Providers (CONSIDER). Kochhar S, Dubé E, Graham J et al. Vaccine, 2021, https://doi.org/10.1016/j.vaccine.2021.03.060
Planning for COVID-19 Vaccines Safety surveillance. Kochhar S, Salmon D. Vaccine, 2020. https://doi.org/10.1016/j.vaccine.2020.07.013
The Brighton Collaboration Standardized Template for Collection of Key Information for Benefit-Risk Assessment of Protein Vaccines. Kochhar S, Kim D, Excler JL et al. Vaccine, 2020. https://doi.org/10.1016/j.vaccine.2020.06.044
Introduction of New Vaccines for Immunization in Pregnancy- Programmatic, Regulatory and Safety Considerations. Kochhar S, Edwards K, Ortiz J et al. Vaccine 2019, 37:25, 3267-3277. https://doi.org/10.1016/j.vaccine.2019.04.075
Immunization in pregnancy clinical research in low- and middle-income countries - Study design, regulatory and safety considerations. Kochhar S, Bonhoeffer J, Jones CE, et al. Vaccine. 2017;35(48 Pt A):6575-6581. doi:10.1016/j.vaccine.2017.03.103